| Authors: |
Krisch JM; Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY, USA., Ermoian RP; Department of Radiation Oncology, University of Washington/ Fred Hutchinson Cancer Center, Seattle, WA, USA., Indelicato DJ; Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA., Lee JY; Procure Proton Therapy Center, Somerset, NJ, USA., Perentesis JP; Division of Oncology, Cincinnati Children's Hospital, Cincinnati, OH, USA., Perkins SM; Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, USA., Laack NN 2nd; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Chang JH; Oklahoma Proton Center, Oklahoma City, OK, USA., MacEwan IJ; Department of Radiation and Applied Sciences, University of California, San Diego, La Jolla, CA, USA., Wolden SL; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wang D; Department of Public Health and Preventative Medicine, SUNY Upstate Medical University, Syracuse, NY, USA., Yock TI; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA., Aridgides PD; Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY, USA. aridgidp@upstate.edu. |
